PG Electroplast Limited Board Meeting Rescheduled Due to Medical Exigency

PG Electroplast Limited has announced the rescheduling of its upcoming Board of Directors meeting. Originally planned for an earlier date, the meeting will now be held on Wednesday, May 27, 2026. The decision to shift the date is attributed to an unforeseen medical exigency involving a key managerial member of the company. The meeting will be conducted via video conferencing to consider and approve previously scheduled corporate business items.

Updated Meeting Schedule

The company has formally notified the stock exchanges that the scheduled Board of Directors meeting has been postponed. The revised date for the meeting is May 27, 2026. This session will be held virtually to ensure all planned corporate agendas are addressed in accordance with the company’s initial development plans.

Trading Window Implications

In accordance with the company’s insider trading policies, the trading window for all designated persons, directors, and key managerial personnel will remain closed. This restriction has been in effect since April 01, 2026, and is slated to continue through May 29, 2026. Market participants should note that the trading window is scheduled to officially re-open on June 01, 2026.

Clarification on Rescheduling

Management has emphasized that the rescheduling is strictly due to the cited medical exigency. There are no other underlying factors or strategic changes influencing this shift in the meeting timeline. The company remains committed to maintaining transparency and fulfilling its disclosure obligations to all stakeholders.

Source: BSE

Previous Article

Wipro Completes Acquisition of Mindsprint to Boost AI-Powered Agribusiness Solutions

Next Article

Texmaco Rail & Engineering Ltd. Clarification on Long Term Incentive Plan